Az etofenamat iontoforezissel elerheto szintje a szerumban es a synovialis folyadekban

Translated title of the contribution: Detectable etofenamate concentration in serum and synovia by means of iontophoresis

T. Bender, J. Bariska, B. Rojkovich, G. Bálint

Research output: Contribution to journalArticle

Abstract

INTRODUCTION - When using percutaneous non-steroidal antiinflammatory drugs a good level of clinical effect and local cyclooxigenase inhibition equal to the use of oral drug administration can be achieved, while getting a lower serum level and having lower side effects. Iontophoresis allows the amount of medicine intake to be increased. Percutaneous NSAID treatment is suitable for decreasing the inflammation of the superficial joints. In spite of this fact there are few studies evaluating the synovial concentration of NSAIDs after the iontophoretic treatment. PATIENTS AND METHODSTHODS - The penetration of etofenamate by means of iontophoresis was examined. Iontophoresis was applied on five consecutive days, with a twenty minute duration, to the lumbar region of eleven patients suffering from lower back pain, and to the knee of thirteen patients suffering from chronic synovitis. After the fifth treatment the serum and synovial etofenamate levels were measured with high pressure liquid cromatography. RESULTS - The drug was detected in the plasma, and in the synovial fluid respectively, and twice with higher concentration in the latter one. CONCLUSION - The authors suggest that etofenamate is an effective topical therapy instead of dionin, lidocaine and novocain to treat patients who have inflammation of the underlying soft tissues.

Original languageHungarian
Pages (from-to)186-189
Number of pages4
JournalLege Artis Medicinae
Volume9
Issue number3
Publication statusPublished - 1999

Fingerprint

Iontophoresis
Synovial Fluid
Non-Steroidal Anti-Inflammatory Agents
Serum
Inflammation
Lumbosacral Region
Procaine
Synovitis
Therapeutics
Lidocaine
Low Back Pain
Pharmaceutical Preparations
Oral Administration
Knee
Anti-Inflammatory Agents
Joints
Medicine
Pressure
etofenamate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az etofenamat iontoforezissel elerheto szintje a szerumban es a synovialis folyadekban. / Bender, T.; Bariska, J.; Rojkovich, B.; Bálint, G.

In: Lege Artis Medicinae, Vol. 9, No. 3, 1999, p. 186-189.

Research output: Contribution to journalArticle

@article{108e07c3a4e443a3905bc740791176c5,
title = "Az etofenamat iontoforezissel elerheto szintje a szerumban es a synovialis folyadekban",
abstract = "INTRODUCTION - When using percutaneous non-steroidal antiinflammatory drugs a good level of clinical effect and local cyclooxigenase inhibition equal to the use of oral drug administration can be achieved, while getting a lower serum level and having lower side effects. Iontophoresis allows the amount of medicine intake to be increased. Percutaneous NSAID treatment is suitable for decreasing the inflammation of the superficial joints. In spite of this fact there are few studies evaluating the synovial concentration of NSAIDs after the iontophoretic treatment. PATIENTS AND METHODSTHODS - The penetration of etofenamate by means of iontophoresis was examined. Iontophoresis was applied on five consecutive days, with a twenty minute duration, to the lumbar region of eleven patients suffering from lower back pain, and to the knee of thirteen patients suffering from chronic synovitis. After the fifth treatment the serum and synovial etofenamate levels were measured with high pressure liquid cromatography. RESULTS - The drug was detected in the plasma, and in the synovial fluid respectively, and twice with higher concentration in the latter one. CONCLUSION - The authors suggest that etofenamate is an effective topical therapy instead of dionin, lidocaine and novocain to treat patients who have inflammation of the underlying soft tissues.",
keywords = "Etofenamate, Iontophoresis, Soft tissue rheumatism, Synovia",
author = "T. Bender and J. Bariska and B. Rojkovich and G. B{\'a}lint",
year = "1999",
language = "Hungarian",
volume = "9",
pages = "186--189",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "3",

}

TY - JOUR

T1 - Az etofenamat iontoforezissel elerheto szintje a szerumban es a synovialis folyadekban

AU - Bender, T.

AU - Bariska, J.

AU - Rojkovich, B.

AU - Bálint, G.

PY - 1999

Y1 - 1999

N2 - INTRODUCTION - When using percutaneous non-steroidal antiinflammatory drugs a good level of clinical effect and local cyclooxigenase inhibition equal to the use of oral drug administration can be achieved, while getting a lower serum level and having lower side effects. Iontophoresis allows the amount of medicine intake to be increased. Percutaneous NSAID treatment is suitable for decreasing the inflammation of the superficial joints. In spite of this fact there are few studies evaluating the synovial concentration of NSAIDs after the iontophoretic treatment. PATIENTS AND METHODSTHODS - The penetration of etofenamate by means of iontophoresis was examined. Iontophoresis was applied on five consecutive days, with a twenty minute duration, to the lumbar region of eleven patients suffering from lower back pain, and to the knee of thirteen patients suffering from chronic synovitis. After the fifth treatment the serum and synovial etofenamate levels were measured with high pressure liquid cromatography. RESULTS - The drug was detected in the plasma, and in the synovial fluid respectively, and twice with higher concentration in the latter one. CONCLUSION - The authors suggest that etofenamate is an effective topical therapy instead of dionin, lidocaine and novocain to treat patients who have inflammation of the underlying soft tissues.

AB - INTRODUCTION - When using percutaneous non-steroidal antiinflammatory drugs a good level of clinical effect and local cyclooxigenase inhibition equal to the use of oral drug administration can be achieved, while getting a lower serum level and having lower side effects. Iontophoresis allows the amount of medicine intake to be increased. Percutaneous NSAID treatment is suitable for decreasing the inflammation of the superficial joints. In spite of this fact there are few studies evaluating the synovial concentration of NSAIDs after the iontophoretic treatment. PATIENTS AND METHODSTHODS - The penetration of etofenamate by means of iontophoresis was examined. Iontophoresis was applied on five consecutive days, with a twenty minute duration, to the lumbar region of eleven patients suffering from lower back pain, and to the knee of thirteen patients suffering from chronic synovitis. After the fifth treatment the serum and synovial etofenamate levels were measured with high pressure liquid cromatography. RESULTS - The drug was detected in the plasma, and in the synovial fluid respectively, and twice with higher concentration in the latter one. CONCLUSION - The authors suggest that etofenamate is an effective topical therapy instead of dionin, lidocaine and novocain to treat patients who have inflammation of the underlying soft tissues.

KW - Etofenamate

KW - Iontophoresis

KW - Soft tissue rheumatism

KW - Synovia

UR - http://www.scopus.com/inward/record.url?scp=0032923415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032923415&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032923415

VL - 9

SP - 186

EP - 189

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 3

ER -